Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.895 USD | -1.30% | -14.13% | -80.48% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.48% | 52Cr | |
+10.91% | 23TCr | |
+14.72% | 20TCr | |
+18.42% | 14TCr | |
+30.86% | 11TCr | |
+0.84% | 6.42TCr | |
+18.70% | 5.41TCr | |
+5.82% | 5.14TCr | |
+10.08% | 4.53TCr | |
+5.39% | 3.73TCr |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- Morgan Stanley Raises Pacific Biosciences of California's Price Target to $12 From $10, Maintains Equalweight Rating